Bausch Health Companies Inc.

NYSE:BHC

Drug Manufacturers - Specialty & Generic

Healthcare
$8.73 -2.21%

-$0.11 today

Market cap
$3.27B
Beta
0.41
P/E (TTM)
-1.5
EPS (TTM)
-$3.19
52W Low $4.57High $8.69

Volume 6.83M

Average 1.70M

BHC Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Bausch Health Companies Inc.NYSE: BHC

Weighted Avg Shares (Diluted) · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares (diluted) grows in line with its trailing trend

Q2 FY2026 weighted avg shares (diluted) of 378.1M shares rose 1.3% year over year, in line with the +0.9% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 1.4% from the prior quarter. Over 3 fiscal years it compounded at +1.2% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +1.3% holds above the trailing-twelve-month pace of +0.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
378.1M+1.4% QoQ
Last fiscal yearDec 2025
375M+1.9% YoY
LTMJun 2026
374.23M+0.9% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.3%——
1 year+1.9%——
3-year CAGR+1.2%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
375M USD
Year-over-year change
+1.9%
4-year CAGR
+1.1%

Weighted Avg Shares (Diluted) vs competitors

How BHC compares with its peers on the latest reported figures

  • BHC's LTM Jun 2026 weighted avg shares (diluted) of 374.23M shares is the highest of the 11 companies compared; the peer median is 127.55M shares.
  • Its year-over-year change of +0.9% is the 7th highest of 11, against a peer median of +1.1%.
  • Over three fiscal years its annual growth of +1.2% compares with a peer median of +2.8%.
BHC Competitors Peer median
Weighted Avg Shares (Diluted) for BHC and competitors
Company Period LTM YoY 3-year CAGR
BHCBausch Health Companies Inc.LTM Jun 2026374.23M +0.9%+1.2%
ALVOAlvotechLTM Mar 2026305.77M +6.0%+12.2%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026199.58M -1.4%-2.6%
HCMHUTCHMED (China) LimitedLTM Jun 2025174.57M +1.2%+1.0%
PRGOPerrigo Company plcLTM Jun 2026138.93M +0.9%+1.0%
CONConcentra Group Holdings Parent, Inc.LTM Sep 2026127.9M +0.1%+0.4%
CPRXCatalyst Pharmaceuticals, Inc.LTM Mar 2026127.2M +1.1%+4.5%
BEAMBeam Therapeutics Inc.LTM Jun 2026103.77M +17.0%+12.2%
MLYSMineralys Therapeutics, Inc.LTM Jun 202679.68M +45.9%+135.7%
HAEHaemonetics CorporationLTM Jun 202646.64M -6.6%-2.7%
ANIPANI Pharmaceuticals, Inc.LTM Mar 202621.04M +7.6%+9.3%
Peer median (excluding BHC) 127.55M+1.1%+2.8%

Competitors are the stored peer set for BHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue8.43B8.12B8.76B9.63B10.27B
Cost of Revenue2.39B2.36B2.56B2.78B3.01B
Gross Profit6.04B5.76B6.2B6.84B7.25B
Gross Margin71.6%70.9%70.8%71.1%70.7%
Research & Development473M530M604M634M629M
Selling, General & Admin2.49B2.53B2.9B3.28B3.44B
Operating Expenses5.59B5.31B5.24B5.3B5.07B
Depreciation & Amortization1.55B1.39B1.26B1.27B1.21B
EBITDA3.26B2.88B2.89B3.13B3.18B
EBITDA Margin38.7%35.4%32.9%32.6%31.0%
Operating Income450M454M963M1.55B2.19B
Operating Margin5.3%5.6%11.0%16.1%21.3%
Interest Income7M14M26M33M48M
Interest Expense1.43B1.46B1.33B1.39B1.6B
Other Income / Expenses(1.47B)(583M)(1.35B)(1.38B)(1.82B)
Income Before Tax(1.02B)(129M)(390M)167M367M
Pre-Tax Margin-12.1%-1.6%-4.5%1.7%3.6%
Income Tax Expense(87M)83M221M239M247M
Net Income(948M)(225M)(592M)(46M)157M
Net Margin-11.2%-2.8%-6.8%-0.5%1.5%
EPS (Basic)(2.61)(0.62)(1.62)(0.13)0.43
EPS (Diluted)(2.61)(0.62)(1.62)(0.13)0.43
Weighted Avg Shares358.9M362M364.9M368M370.9M
Weighted Avg Shares (Diluted)358.9M362M364.9M368M375M

Bausch Health Companies Inc.

NYSE:BHC

Intrinsic Alpha fair value

Locked

Current Price

$8.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.